Cargando…
The Role of microRNAs in Multidrug Resistance of Glioblastoma
SIMPLE SUMMARY: Glioblastoma (GBM) is one of the most malignant types of central nervous system tumor which accounts for more than 60% of all brain tumors in adults. Owing to poor prognosis and drug resistance of most GBM, it is urged to further develop the diagnosis and treatment strategies. The ai...
Autores principales: | Mahinfar, Parvaneh, Mansoori, Behnaz, Rostamzadeh, Davoud, Baradaran, Behzad, Cho, William C., Mansoori, Behzad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265057/ https://www.ncbi.nlm.nih.gov/pubmed/35804989 http://dx.doi.org/10.3390/cancers14133217 |
Ejemplares similares
-
Long Non-Coding RNAs in Multidrug Resistance of Glioblastoma
por: Mahinfar, Parvaneh, et al.
Publicado: (2021) -
Metabolic Pathways in Breast Cancer Reprograming: An Insight to Non-Coding RNAs
por: Abedi-Gaballu, Fereydoon, et al.
Publicado: (2022) -
Antiproliferative activity of CD44 siRNA-PEI-PEG nanoparticles in glioblastoma: involvement of AKT signaling
por: Mahinfar, Parvaneh, et al.
Publicado: (2021) -
The Different Mechanisms of Cancer Drug Resistance: A Brief Review
por: Mansoori, Behzad, et al.
Publicado: (2017) -
mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment
por: Mafi, Sahar, et al.
Publicado: (2022)